A Phase Ib Study of RC1416 Injection

NCT06911866 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Asthma

Interventions

DRUG: RC1416
DRUG: RC1416 Placebo

Sponsor

Nanjing RegeneCore Biotech Co., Ltd.